Cerebral Edema in Traumatic Brain Injury: Pathophysiology and Prospective Therapeutic Targets.
暂无分享,去创建一个
John K Yue | Geoffrey T Manley | John K. Yue | G. Manley | E. Winkler | Ethan A Winkler | Daniel Minter | Daniel Minter | J. Yue
[1] I. Klatzo. Pathophysiological aspects of brain edema , 2004, Acta Neuropathologica.
[2] K. Fountas,et al. AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. , 2014, Journal of neurotrauma.
[3] J. Pickard,et al. Continuous monitoring of the Monro-Kellie doctrine: is it possible? , 2012, Journal of neurotrauma.
[4] U. Dirnagl,et al. Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke , 2007, Stroke.
[5] K. Kiening,et al. Glibenclamide reduces secondary brain damage after experimental traumatic brain injury , 2014, Neuroscience.
[6] P. Couraud,et al. Methamphetamine Disrupts Blood–Brain Barrier Function by Induction of Oxidative Stress in Brain Endothelial Cells , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] J. Simard,et al. Sulfonylurea receptor 1 in central nervous system injury: a focused review , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] B. MacVicar,et al. The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema , 2015, Cell.
[9] G. Rosenberg. Matrix metalloproteinases in neuroinflammation , 2002, Glia.
[10] R. Deane,et al. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. , 2010, Blood.
[11] C. Bennett,et al. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats , 2004, Neuropeptides.
[12] Geoffrey T Manley,et al. Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method. , 2004, American journal of physiology. Cell physiology.
[13] S. Moreno,et al. Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS , 2004, Neuroscience.
[14] J. Yi,et al. PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms , 2008, Brain Research.
[15] Berislav V. Zlokovic,et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.
[16] B. Zlokovic,et al. The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease? , 2014, Brain pathology.
[17] J. Simard,et al. Functional Coupling between Sulfonylurea Receptor Type 1 and a Nonselective Cation Channel in Reactive Astrocytes from Adult Rat Brain , 2003, The Journal of Neuroscience.
[18] J. Simard,et al. Cell Swelling and a Nonselective Cation Channel Regulated by Internal Ca2+ and ATP in Native Reactive Astrocytes from Adult Rat Brain , 2001, The Journal of Neuroscience.
[19] X. Chen,et al. Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury , 2005, Neuroscience Letters.
[20] D. Kondziolka,et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.
[21] D. Stewart,et al. Pathology and new players in the pathogenesis of brain edema , 2009, Acta Neuropathologica.
[22] J. Simard,et al. Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. , 2010, Journal of neurosurgery.
[23] A. Shetty,et al. Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves , 2014, Front. Cell. Neurosci..
[24] Grant Bochicchio,et al. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. , 2009, Journal of neurotrauma.
[25] Jens P Dreier,et al. Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex , 2004, The Journal of Neuroscience.
[26] G. Rosenberg,et al. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. , 2007, Neurosurgical focus.
[27] N. Stocchetti,et al. Time course of intracranial hypertension after traumatic brain injury. , 2007, Journal of neurotrauma.
[28] R. Vink,et al. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments , 2010, Current opinion in neurology.
[29] K. Monson,et al. Distribution of Blood–Brain Barrier Disruption in Primary Blast Injury , 2013, Annals of Biomedical Engineering.
[30] K. Lu,et al. NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade , 2008, Critical care medicine.
[31] G. Manley,et al. Role of water channels in fluid transport studied by phenotype analysis of aquaporin knockout mice , 2000, Experimental physiology.
[32] T. Kawase,et al. Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats , 2009, Brain Research.
[33] Ø. Skare,et al. Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signaling events elicited by cerebral edema , 2010, Proceedings of the National Academy of Sciences.
[34] S. Ansari,et al. Role of vasopressin and its antagonism in stroke related edema , 2014, Journal of neuroscience research.
[35] Kevin M. Curtis,et al. Na‐K‐Cl cotransporter‐1 in the mechanism of cell swelling in cultured astrocytes after fluid percussion injury , 2011, Journal of neurochemistry.
[36] Berislav V. Zlokovic,et al. Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.
[37] A. Fukuda,et al. Development and regulation of chloride homeostasis in the central nervous system , 2015, Front. Cell. Neurosci..
[38] O. Tasaki,et al. Delayed Progression of Edema Formation Around a Hematoma Expressing High Levels of VEGF and MMP-9 in a Patient With Traumatic Brain Injury: Case Report , 2013, Neurologia medico-chirurgica.
[39] Odette A. Harris,et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition , 2016, Neurosurgery.
[40] R. Dempsey,et al. Inhibition of Na+–K+–Cl− cotransporter during focal cerebral ischemia decreases edema and neuronal damage , 2003, Brain Research.
[41] Kirsten M. Lynch,et al. Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury. , 2010, Journal of neurotrauma.
[42] R. Vink,et al. A substance P antagonist improves outcome when administered 4h after onset of ischaemic stroke , 2011, Brain Research.
[43] N. Plesnila,et al. Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice. , 2015, Journal of neurotrauma.
[44] M. Papadopoulos,et al. Aquaporins: important but elusive drug targets , 2014, Nature Reviews Drug Discovery.
[45] J. Duncan,et al. Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury , 2003, Neuroscience.
[46] J. Simard,et al. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas , 2012, Annals of neurology.
[47] P. Sandercock,et al. Corticosteroids for acute ischaemic stroke. , 2011, The Cochrane database of systematic reviews.
[48] M. Fini,et al. Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] G. Manley,et al. Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[51] Peter Bragge,et al. Early management of severe traumatic brain injury , 2012, The Lancet.
[52] L. Pitts,et al. Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation. , 1992, Journal of neurotrauma.
[53] J. Rafols,et al. Pericyte migration from the vascular wall in response to traumatic brain injury. , 2000, Microvascular research.
[54] B. Zlokovic,et al. Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.
[55] H. Young,et al. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury , 2014, Brain Research.
[56] Jesse D. Sengillo,et al. Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice , 2014, Proceedings of the National Academy of Sciences.
[57] R. Vink,et al. Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury , 2011, Neurotherapeutics.
[58] J. Szmydynger-Chodobska,et al. Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury , 2011, Translational Stroke Research.
[59] Q. Tu,et al. NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia–reperfusion damage , 2014, Neurological research.
[60] J. Rafols,et al. Differential expression of capillary VEGF isoforms following traumatic brain injury , 2007, Neurological research.
[61] Guo-yi Gao,et al. MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat. , 2014, Journal of neurotrauma.
[62] R. Vink,et al. Substance P immunoreactivity increases following human traumatic brain injury. , 2010, Acta neurochirurgica. Supplement.
[63] S. Yuan,et al. Myosin light chain kinase in microvascular endothelial barrier function. , 2010, Cardiovascular research.
[64] K. Furie,et al. Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients , 2013, Neurocritical Care.
[65] J. Simard,et al. Pilot Study of Intravenous Glyburide in Patients With a Large Ischemic Stroke , 2014, Stroke.
[66] A. Marmarou,et al. Bolus tracer delivery measured by MRI confirms edema without blood-brain barrier permeability in diffuse traumatic brain injury. , 2006, Acta neurochirurgica. Supplement.
[67] R. Vink,et al. A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. , 2011, Journal of neurotrauma.
[68] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[69] Frank J. Yuk,et al. Selective vulnerability of the cerebral vasculature to blast injury in a rat model of mild traumatic brain injury , 2014, Acta neuropathologica communications.
[70] R. Mccoll,et al. Cytotoxic and vasogenic cerebral oedema in traumatic brain injury: Assessment with FLAIR and DWI imaging , 2014, Brain injury.
[71] G. Manley,et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke , 2000, Nature Medicine.
[72] Guy C. Brown,et al. Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons , 2010, Molecular Neurobiology.
[73] Donald W. Miller,et al. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. , 2005, Alcoholism, clinical and experimental research.
[74] K. Engelhard,et al. Inhibition of Proteasomal Glucocorticoid Receptor Degradation Restores Dexamethasone-Mediated Stabilization of the Blood–Brain Barrier After Traumatic Brain Injury* , 2013, Critical care medicine.
[75] W. Su,et al. Changes and effects of plasma arginine vasopressin in traumatic brain injury , 2008, Journal of endocrinological investigation.
[76] E. Nagelhus,et al. Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1 , 2004, Neuroscience.
[77] N. Chandra,et al. Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. , 2013, Free radical biology & medicine.
[78] Wade R. Smith,et al. Peroxisome Proliferator-Activated Receptors: “Key” Regulators of Neuroinflammation after Traumatic Brain Injury , 2008, PPAR research.
[79] W. Sibley,et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. , 2000, The Cochrane database of systematic reviews.
[80] A. Marmarou,et al. Pathophysiology of traumatic brain edema: current concepts. , 2003, Acta neurochirurgica. Supplement.
[81] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[82] G. Bing,et al. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury , 2011, Experimental Neurology.
[83] Anthony Marmarou,et al. Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries. , 2006, Journal of neurosurgery.
[84] Heiko J. Luhmann,et al. Traumatic brain injury results in rapid pericyte loss followed by reactive pericytosis in the cerebral cortex , 2015, Scientific Reports.
[85] Anthony Marmarou,et al. A review of progress in understanding the pathophysiology and treatment of brain edema. , 2007, Neurosurgical focus.
[86] E. Shohami,et al. Vascular Endothelial Growth Factor Increases Neurogenesis after Traumatic Brain Injury , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[87] H. Luhmann,et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury , 2010, Journal of neurochemistry.
[88] A. Biegon,et al. Novel approach to the role of NMDA receptors in traumatic brain injury. , 2014, CNS & neurological disorders drug targets.
[89] A. Marmarou,et al. Secondary ischemia impairing the restoration of ion homeostasis following traumatic brain injury. , 2005, Journal of neurosurgery.
[90] Pamela S. Jones,et al. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. , 2009, Physiology.
[91] B. N. Tomlinson,et al. Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury , 2013, PloS one.
[92] Miikka Vikkula,et al. Cerebrovascular disorders: molecular insights and therapeutic opportunities , 2011, Nature Neuroscience.
[93] D. Stewart,et al. Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury , 2011, Neuropathology and applied neurobiology.
[94] C. Förster,et al. Glucocorticoids and endothelial cell barrier function , 2013, Cell and Tissue Research.
[95] P. Hof,et al. Vascular and Inflammatory Factors in the Pathophysiology of Blast-Induced Brain Injury , 2015, Front. Neurol..
[96] G. Manley,et al. Mildly Reduced Brain Swelling and Improved Neurological Outcome in Aquaporin-4 Knockout Mice following Controlled Cortical Impact Brain Injury. , 2015, Journal of neurotrauma.
[97] A. Obenaus,et al. Posttraumatic Reduction of Edema with Aquaporin-4 RNA Interference Improves Acute and Chronic Functional Recovery , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[98] G. Manley,et al. Aquaporins: role in cerebral edema and brain water balance. , 2007, Progress in brain research.
[99] Michael Chopp,et al. Animal models of traumatic brain injury , 2013, Nature Reviews Neuroscience.
[100] P. Kochanek,et al. Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup , 2014 .
[101] A. Maas,et al. Traumatic intracranial hypertension. , 2014, The New England journal of medicine.
[102] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[103] N. van Bruggen,et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.
[104] G. Manley,et al. Aquaporin-1 deletion reduces osmotic water permeability and cerebrospinal fluid production. , 2003, Acta neurochirurgica. Supplement.
[105] J. Rafols,et al. Hypoxia-inducible factor-1α signaling in aquaporin upregulation after traumatic brain injury , 2009, Neuroscience Letters.
[106] J. Langlois,et al. The Epidemiology and Impact of Traumatic Brain Injury: A Brief Overview , 2006, The Journal of head trauma rehabilitation.
[107] M. Wald,et al. Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006 , 2010 .
[108] K. Mori,et al. Temporal profile of changes in brain tissue extracellular space and extracellular ion (Na(+), K(+)) concentrations after cerebral ischemia and the effects of mild cerebral hypothermia. , 2002, Journal of neurotrauma.
[109] Geoffrey T Manley,et al. Traumatic brain injury: an international knowledge-based approach. , 2013, JAMA.
[110] S. Meuth,et al. Glucocorticoid Insensitivity at the Hypoxic Blood–Brain Barrier Can Be Reversed by Inhibition of the Proteasome , 2011, Stroke.
[111] H. Yonas,et al. ELEVATION OF MATRIX METALLOPROTEINASES 3 AND 9 IN CEREBROSPINAL FLUID AND BLOOD IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY , 2009, Neurosurgery.
[112] A. Dray,et al. Kinins and kinin receptors in the nervous system , 1995, Neurochemistry International.
[113] B. Palmier,et al. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. , 2007, Journal of neurotrauma.
[114] R. Bullock,et al. Moderate and severe traumatic brain injury in adults , 2008, The Lancet Neurology.
[115] B. N. Tomlinson,et al. Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury. , 2015, ACS chemical neuroscience.
[116] H. Luhmann,et al. Inhibition of the myosin light chain kinase prevents hypoxia‐induced blood–brain barrier disruption , 2007, Journal of neurochemistry.
[117] V. Perry,et al. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo , 1998, Neuroscience.
[118] David W Wright,et al. Position statement: definition of traumatic brain injury. , 2010, Archives of physical medicine and rehabilitation.
[119] B. Masel,et al. Traumatic brain injury: a disease process, not an event. , 2010, Journal of neurotrauma.
[120] T. Kondoh,et al. Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model. , 2007, The Kobe journal of medical sciences.
[121] P. Alderson,et al. Corticosteroids for acute traumatic brain injury. , 2005, The Cochrane database of systematic reviews.
[122] Odette A. Harris,et al. Guidelines for the management of severe traumatic brain injury. XV. Steroids. , 2007, Journal of neurotrauma.
[123] L. Belayev,et al. Inhibition of Myosin light-chain kinase attenuates cerebral edema after traumatic brain injury in postnatal mice. , 2013, Journal of neurotrauma.
[124] A. Marmarou,et al. The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. , 2000, Acta neurochirurgica. Supplement.
[125] C. Baumgarten,et al. Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats. , 2014, Journal of neurotrauma.
[126] R. McCarron,et al. Increase in blood–brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast‐induced traumatic brain injury , 2010, Journal of neuroscience research.
[127] J. Simard,et al. Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke , 2006, Nature Medicine.
[128] R. Bordet,et al. Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier , 2009 .
[129] H. Nakase,et al. Vascular Endothelial Growth Factor Antagonist Reduces Brain Edema Formation and Venous Infarction , 2005, Stroke.
[130] S. Thal,et al. The blood-brain barrier as a target in traumatic brain injury treatment. , 2014, Archives of medical research.
[131] S. Wisniewski,et al. Vascular Endothelial Growth Factor Is Increased in Cerebrospinal Fluid after Traumatic Brain Injury in Infants and Children , 2004, Neurosurgery.
[132] G. Manley,et al. The role of aquaporin-4 in cerebral water transport and edema. , 2007, Neurosurgical focus.
[133] Jesse D. Sengillo,et al. Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[134] C. Löhr,et al. Localization of myosin II regulatory light chain in the cerebral vasculature. , 2008, Acta histochemica.
[135] J. Rafols,et al. Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and HIF1α after traumatic brain injury (TBI) , 2012, Journal of the Neurological Sciences.
[136] D. Kintner,et al. Na+-Dependent Chloride Transporter (NKCC1)-Null Mice Exhibit Less Gray and White Matter Damage after Focal Cerebral Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[137] K. Lu,et al. Inhibition of the Na+ -K+ -2Cl- -cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage. , 2006, European journal of pharmacology.
[138] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[139] R. Vink,et al. Substance P is Associated with the Development of Brain Edema and Functional Deficits after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[140] J. Marc Simard,et al. Novel Treatment Targets for Cerebral Edema , 2011, Neurotherapeutics.
[141] B. Aarabi,et al. Intracranial Pressure Dose and Outcome in Traumatic Brain Injury , 2013, Neurocritical Care.
[142] J. Szmydynger-Chodobska,et al. Multiple Sites of Vasopressin Synthesis in the Injured Brain , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[143] José Luís Alves,et al. Blood–brain barrier and traumatic brain injury , 2014, Journal of neuroscience research.